Top

Published in:

01-01-2018 | Review

Periostin in cardiovascular disease and development: a tale of two distinct roles

Authors: Natalie M. Landry, Smadar Cohen, Ian M. C. Dixon

Published in: Basic Research in Cardiology | Issue 1/2018

Abstract

Tissue development and homeostasis are dependent upon the concerted synthesis, maintenance, and degradation of extracellular matrix (ECM) molecules. Cardiac fibrosis is now recognized as a primary contributor to incidence of heart failure, particularly heart failure with preserved ejection fraction, wherein cardiac filling in diastole is compromised. Periostin is a cell-associated protein involved in cell fate determination, proliferation, tumorigenesis, and inflammatory responses. As a non-structural component of the ECM, secreted 90 kDa periostin is emerging as an important matricellular factor in cardiac mesenchymal tissue development. In addition, periostin’s role as a mediator in cell–matrix crosstalk has also garnered attention for its association with fibroproliferative diseases in the myocardium, and for its association with TGF-β/BMP signaling. This review summarizes the phylogenetic history of periostin, its role in cardiac development, and the major signaling pathways influencing its expression in cardiovascular pathology. Further, we provide a synthesis of the current literature to distinguish the multiple roles of periostin in cardiac health, development and disease. As periostin may be targeted for therapeutic treatment of cardiac fibrosis, these insights may shed light on the putative timing for application of periostin-specific therapies.

Acharya A, Baek ST, Huang G, Eskiocak B, Goetsch S, Sung CY, Banfi S, Sauer MF, Olsen GS, Duffield JS, Olson EN, Tallquist MD (2012) The bHLH transcription factor Tcf21 is required for lineage-specific EMT of cardiac fibroblast progenitors. Development 139:2139–2149. doi:10.1242/dev.079970 PubMedPubMedCentralCrossRef

Alfieri CM, Cheek J, Chakraborty S, Yutzey KE (2010) Wnt signaling in heart valve development and osteogenic gene induction. Dev Biol 338:127–135. doi:10.1016/j.ydbio.2009.11.030 PubMedCrossRef

Ali O, Guillou H, Destaing O, Albiges-Rizo C, Block MR, Fourcade B (2011) Cooperativity between integrin activation and mechanical stress leads to integrin clustering. Biophys J 100:2595–2604. doi:10.1016/j.bpj.2011.03.028 PubMedPubMedCentralCrossRef

Ameling S, Bhardwaj G, Hammer E, Beug D, Steil L, Reinke Y, Weitmann K, Grube M, Trimpert C, Klingel K, Kandolf R, Hoffmann W, Nauck M, Dorr M, Empen K, Felix SB, Volker U (2016) Changes of myocardial gene expression and protein composition in patients with dilated cardiomyopathy after immunoadsorption with subsequent immunoglobulin substitution. Basic Res Cardiol 111:53. doi:10.1007/s00395-016-0569-y PubMedCrossRef

Ashley SL, Wilke CA, Kim KK, Moore BB (2017) Periostin regulates fibrocyte function to promote myofibroblast differentiation and lung fibrosis. Mucosal Immunol 10:341–351. doi:10.1038/mi.2016.61 PubMedCrossRef

Asli N, Xaymardan M, Harvey R (2014) Epicardial origin of resident mesenchymal stem cells in the adult mammalian heart. J Dev Biol 2:117–137. doi:10.3390/jdb2020117 CrossRef

Bai Y, Nakamura M, Zhou G, Li Y, Liu Z, Ozaki T, Mori I, Kakudo K (2010) Novel isoforms of periostin expressed in the human thyroid. Jpn Clin Med 1:13–20. doi:10.4137/JCM.S5899 PubMedPubMedCentralCrossRef

Bao S, Ouyang G, Bai X, Huang Z, Ma C, Liu M, Shao R, Anderson RM, Rich JN, Wang XF (2004) Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. Cancer Cell 5:329–339. doi:10.1016/S1535-6108(04)00081-9 PubMedCrossRef

Bastiani MJ, Harrelson AL, Snow PM, Goodman CS (1987) Expression of fasciclin I and II glycoproteins on subsets of axon pathways during neuronal development in the grasshopper. Cell 48:745–755. doi:10.1016/0092-8674(87)90072-9 PubMedCrossRef

10.

Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, Bussani R, Nadal-Ginard B, Silvestri F, Leri A, Beltrami CA, Anversa P (2001) Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 344:1750–1757. doi:10.1056/NEJM200106073442303 PubMedCrossRef

11.

Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabe-Heider F, Walsh S, Zupicich J, Alkass K, Buchholz BA, Druid H, Jovinge S, Frisen J (2009) Evidence for cardiomyocyte renewal in humans. Science 324:98–102. doi:10.1126/science.1164680 PubMedPubMedCentralCrossRef

12.

Bieber AJ, Snow PM, Hortsch M, Patel NH, Jacobs JR, Traquina ZR, Schilling J, Goodman CS (1989) Drosophila neuroglian: a member of the immunoglobulin superfamily with extensive homology to the vertebrate neural adhesion molecule L1. Cell 59:447–460. doi:10.1016/0092-8674(89)90029-9 PubMedCrossRef

13.

Bonnet N, Garnero P, Ferrari S (2016) Periostin action in bone. Mol Cell Endocrinol 432:75–82. doi:10.1016/j.mce.2015.12.014 PubMedCrossRef

14.

Burstein B, Nattel S (2008) Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 51:802–809. doi:10.1016/j.jacc.2007.09.064 PubMedCrossRef

15.

Butcher JT, Norris RA, Hoffman S, Mjaatvedt CH, Markwald RR (2007) Periostin promotes atrioventricular mesenchyme matrix invasion and remodeling mediated by integrin signaling through Rho/PI 3-kinase. Dev Biol 302:256–266. doi:10.1016/j.ydbio.2006.09.048 PubMedCrossRef

16.

Callebaut I, Mignotte V, Souchet M, Mornon JP (2003) EMI domains are widespread and reveal the probable orthologs of the Caenorhabditis elegans CED-1 protein. Biochem Biophys Res Commun 300:619–623. doi:10.1016/S0006-291X(02)02904-2 PubMedCrossRef

17.

Chang SH, Yeh YH, Lee JL, Hsu YJ, Kuo CT, Chen WJ (2017) Transforming growth factor-beta-mediated CD44/STAT3 signaling contributes to the development of atrial fibrosis and fibrillation. Basic Res Cardiol 112:58. doi:10.1007/s00395-017-0647-9 PubMedCrossRef

18.

Chen YF, Feng JA, Li P, Xing D, Zhang Y, Serra R, Ambalavanan N, Majid-Hassan E, Oparil S (2006) Dominant negative mutation of the TGF-beta receptor blocks hypoxia-induced pulmonary vascular remodeling. J Appl Physiol 100:564–571. doi:10.1152/japplphysiol.00595.2005 PubMedCrossRef

19.

Chen Z, Xie J, Hao H, Lin H, Wang L, Zhang Y, Chen L, Cao S, Huang X, Liao W, Bin J, Liao Y (2017) Ablation of periostin inhibits post-infarction myocardial regeneration in neonatal mice mediated by the phosphatidylinositol 3 kinase/glycogen synthase kinase 3beta/cyclin D1 signalling pathway. Cardiovasc Res. doi:10.1093/cvr/cvx001 PubMedCentral

20.

Clout NJ, Tisi D, Hohenester E (2003) Novel fold revealed by the structure of a FAS1 domain pair from the insect cell adhesion molecule fasciclin I. Structure 11:197–203. doi:10.1016/S0969-2126(03)00002-9 PubMedCrossRef

21.

Conway SJ, Doetschman T, Azhar M (2011) The inter-relationship of periostin, TGF beta, and BMP in heart valve development and valvular heart diseases. Sci World J 11:1509–1524. doi:10.1100/tsw.2011.132 CrossRef

22.

Cunnington RH, Northcott JM, Ghavami S, Filomeno KL, Jahan F, Kavosh MS, Davies JJ, Wigle JT, Dixon IM (2014) The Ski–Zeb2–Meox2 pathway provides a novel mechanism for regulation of the cardiac myofibroblast phenotype. J Cell Sci 127:40–49. doi:10.1242/jcs.126722 PubMedCrossRef

23.

Cunnington RH, Wang B, Ghavami S, Bathe KL, Rattan SG, Dixon IM (2011) Antifibrotic properties of c-Ski and its regulation of cardiac myofibroblast phenotype and contractility. Am J Physiol Cell Physiol 300:C176–C186. doi:10.1152/ajpcell.00050.2010 PubMedCrossRef

24.

Deheuninck J, Luo K (2009) Ski and SnoN, potent negative regulators of TGF-beta signaling. Cell Res 19:47–57. doi:10.1038/cr.2008.324 PubMedPubMedCentralCrossRef

25.

Dietz H (2014) A healthy tension in translational research. J Clin Investig 124:1425–1429. doi:10.1172/JCI75840 PubMedPubMedCentralCrossRef

26.

Doliana R, Bot S, Bonaldo P, Colombatti A (2000) EMI, a novel cysteine-rich domain of EMILINs and other extracellular proteins, interacts with the gC1q domains and participates in multimerization. FEBS Lett 484:164–168. doi:10.1016/S0014-5793(00)02140-2 PubMedCrossRef

27.

Egbert M, Ruetze M, Sattler M, Wenck H, Gallinat S, Lucius R, Weise JM (2014) The matricellular protein periostin contributes to proper collagen function and is downregulated during skin aging. J Dermatol Sci 73:40–48. doi:10.1016/j.jdermsci.2013.08.010 PubMedCrossRef

28.

Elkins T (1990) Drosophila fasciclin I is a novel homophilic adhesion molecule that along with fasciclin III can mediate cell sorting. J Cell Biol 110:1825–1832. doi:10.1083/jcb.110.5.1825 PubMedCrossRef

29.

Esnault C, Stewart A, Gualdrini F, East P, Horswell S, Matthews N, Treisman R (2014) Rho-actin signaling to the MRTF coactivators dominates the immediate transcriptional response to serum in fibroblasts. Genes Dev 28:943–958. doi:10.1101/gad.239327.114 PubMedPubMedCentralCrossRef

30.

Frangogiannis NG (2012) Matricellular proteins in cardiac adaptation and disease. Physiol Rev 92:635–688. doi:10.1152/physrev.00008.2011 PubMedPubMedCentralCrossRef

31.

Garnero P (2012) The contribution of collagen crosslinks to bone strength. Bonekey Rep 1:182. doi:10.1038/bonekey.2012.182 PubMedPubMedCentralCrossRef

32.

Ghatak S, Misra S, Norris RA, Moreno-Rodriguez RA, Hoffman S, Levine RA, Hascall VC, Markwald RR (2014) Periostin induces intracellular cross-talk between kinases and hyaluronan in atrioventricular valvulogenesis. J Biol Chem 289:8545–8561. doi:10.1074/jbc.M113.539882 PubMedPubMedCentralCrossRef

33.

Gillan L, Matei D, Fishman DA, Gerbin CS, Karlan BY, Chang DD (2002) Periostin secreted by epithelial ovarian carcinoma is a ligand for a_vb₃ and a_vb₅ integrins and promotes cell motility. Cancer Res 62:5358–5364. http://cancerres.aacrjournals.org.uml.idm.oclc.org/content/62/18/5358.long

34.

Guan J, Liu WQ, Xing MQ, Shi Y, Tan XY, Jiang CQ, Dai HY (2015) Elevated expression of periostin in diabetic cardiomyopathy and the effect of valsartan. BMC Cardiovasc Disord 15:90. doi:10.1186/s12872-015-0084-3 PubMedPubMedCentralCrossRef

35.

Hakuno D, Kimura N, Yoshioka M, Fukuda K (2011) Role of angiogenetic factors in cardiac valve homeostasis and disease. J Cardiovasc Transl Res 4:727–740. doi:10.1007/s12265-011-9317-8 PubMedCrossRef

36.

Hakuno D, Kimura N, Yoshioka M, Kimura T, Okada Y, Yozu R, Shukunami C, Hiraki Y, Kudo A, Ogawa S, Fukuda K (2010) Periostin advances atherosclerotic and rheumatic cardiac valve degeneration by induction angiogenesis and MMP production in humans and rodents. J Clin Investig 120:2292–2306. doi:10.1172/jci40973ds1 PubMedPubMedCentralCrossRef

37.

Henderson NC, Arnold TD, Katamura Y, Giacomini MM, Rodriguez JD, McCarty JH, Pellicoro A, Raschperger E, Betsholtz C, Ruminski PG, Griggs DW, Prinsen MJ, Maher JJ, Iredale JP, Lacy-Hulbert A, Adams RH, Sheppard D (2013) Targeting of alphav integrin identifies a core molecular pathway that regulates fibrosis in several organs. Nat Med 19:1617–1624. doi:10.1038/nm.3282 PubMedCrossRef

38.

Hinton RB Jr, Lincoln J, Deutsch GH, Osinska H, Manning PB, Benson DW, Yutzey KE (2006) Extracellular matrix remodeling and organization in developing and diseased aortic valves. Circ Res 98:1431–1438. doi:10.1161/01.RES.0000224114.65109.4e PubMedCrossRef

39.

Horiuchi K, Amizuka N, Takeshita S, Takamatsu H, Katsuura M, Ozawa H, Toyama Y, Bonewald LF, Kudo A (1999) Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res 14:1239–1249. doi:10.1359/jbmr.1999.14.7.1239 PubMedCrossRef

40.

Horne TE, VandeKopple M, Sauls K, Koenig SN, Anstine LJ, Garg V, Norris RA, Lincoln J (2015) Dynamic heterogeneity of the heart valve interstitial cell population in mitral valve health and disease. J Cardiovasc Dev Dis 2:214–232. doi:10.3390/jcdd2030214 PubMedPubMedCentralCrossRef

41.

Idolazzi L, Ridolo E, Fassio A, Gatti D, Montagni M, Caminati M, Martignago I, Incorvaia C, Senna G (2017) Periostin: the bone and beyond. Eur J Intern Med 38:12–16. doi:10.1016/j.ejim.2016.11.015 PubMedCrossRef

42.

Iekushi K, Taniyama Y, Azuma J, Katsuragi N, Dosaka N, Sanada F, Koibuchi N, Nagao K, Ogihara T, Morishita R (2007) Novel mechanisms of valsartan on the treatment of acute myocardial infarction through inhibition of the antiadhesion molecule periostin. Hypertension 49:1409–1414. doi:10.1161/HYPERTENSIONAHA.106.080994 PubMedCrossRef

43.

Imanaka-Yoshida K, Aoki H (2014) Tenascin-C and mechanotransduction in the development and diseases of cardiovascular system. Front Physiol 5:283. doi:10.3389/fphys.2014.00283 PubMedPubMedCentralCrossRef

44.

Inai K, Norris RA, Hoffman S, Markwald RR, Sugi Y (2008) BMP-2 induces cell migration and periostin expression during atrioventricular valvulogenesis. Dev Biol 315:383–396. doi:10.1016/j.ydbio.2007.12.028 PubMedCrossRef

45.

Javan H, Szucsik AM, Li L, Schaaf CL, Salama ME, Selzman CH (2015) Cardiomyocyte p65 nuclear factor-kappaB is necessary for compensatory adaptation to pressure overload. Circ Heart Fail 8:109–118. doi:10.1161/CIRCHEARTFAILURE.114.001297 PubMedCrossRef

46.

Kanisicak O, Khalil H, Ivey MJ, Karch J, Maliken BD, Correll RN, Brody MJ, Lin SC, Aronow BJ, Tallquist MD, Molkentin JD (2016) Genetic lineage tracing defines myofibroblast origin and function in the injured heart. Nat Commun 7:12260. doi:10.1038/ncomms12260 PubMedPubMedCentralCrossRef

47.

Katsumi A, Naoe T, Matsushita T, Kaibuchi K, Schwartz MA (2005) Integrin activation and matrix binding mediate cellular responses to mechanical stretch. J Biol Chem 280:16546–16549. doi:10.1074/jbc.C400455200 PubMedCrossRef

48.

Kii I, Nishiyama T, Li M, Matsumoto K, Saito M, Amizuka N, Kudo A (2010) Incorporation of tenascin-C into the extracellular matrix by periostin underlies an extracellular meshwork architecture. J Biol Chem 285:2028–2039. doi:10.1074/jbc.M109.051961 PubMedCrossRef

49.

Kim BY, Olzmann JA, Choi SI, Ahn SY, Kim TI, Cho HS, Suh H, Kim EK (2009) Corneal dystrophy-associated R124H mutation disrupts TGFBI interaction with Periostin and causes mislocalization to the lysosome. J Biol Chem 284:19580–19591. doi:10.1074/jbc.M109.013607 PubMedPubMedCentralCrossRef

50.

Kruzynska-Frejtag A, Machnicki M, Rogers R, Markwald RR, Conway SJ (2001) Periostin (an osteoblast-specific factor) is expressed within the embryonic mouse heart during valve formation. Mech Dev 103:183–188. doi:10.1016/s0925-4773(01)00356-2 PubMedCrossRef

51.

Kudo A (2011) Periostin in fibrillogenesis for tissue regeneration: periostin actions inside and outside the cell. Cell Mol Life Sci 68:3201–3207. doi:10.1007/s00018-011-0784-5 PubMedPubMedCentralCrossRef

52.

Kuhn B, del Monte F, Hajjar RJ, Chang YS, Lebeche D, Arab S, Keating MT (2007) Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat Med 13:962–969. doi:10.1038/nm1619 PubMedCrossRef

53.

Ladage D, Yaniz-Galende E, Rapti K, Ishikawa K, Tilemann L, Shapiro S, Takewa Y, Muller-Ehmsen J, Schwarz M, Garcia MJ, Sanz J, Hajjar RJ, Kawase Y (2013) Stimulating myocardial regeneration with periostin Peptide in large mammals improves function post-myocardial infarction but increases myocardial fibrosis. PLoS One 8:e59656. doi:10.1371/journal.pone.0059656 PubMedPubMedCentralCrossRef

54.

Latif N, Quillon A, Sarathchandra P, McCormack A, Lozanoski A, Yacoub MH, Chester AH (2015) Modulation of human valve interstitial cell phenotype and function using a fibroblast growth factor 2 formulation. PLoS One 10:e0127844. doi:10.1371/journal.pone.0127844 PubMedPubMedCentralCrossRef

55.

Li G, Jin R, Norris RA, Zhang L, Yu S, Wu F, Markwald RR, Nanda A, Conway SJ, Smyth SS, Granger DN (2010) Periostin mediates vascular smooth muscle cell migration through the integrins alphavbeta3 and alphavbeta5 and focal adhesion kinase (FAK) pathway. Atherosclerosis 208:358–365. doi:10.1016/j.atherosclerosis.2009.07.046 PubMedCrossRef

56.

Li G, Oparil S, Sanders JM, Zhang L, Dai M, Chen LB, Conway SJ, McNamara CA, Sarembock IJ (2006) Phosphatidylinositol-3-kinase signaling mediates vascular smooth muscle cell expression of periostin in vivo and in vitro. Atherosclerosis 188:292–300. doi:10.1016/j.atherosclerosis.2005.11.002 PubMedCrossRef

57.

Li L, Fan D, Wang C, Wang JY, Cui XB, Wu D, Zhou Y, Wu LL (2011) Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-beta1 pathways in cardiac fibroblasts. Cardiovasc Res 91:80–89. doi:10.1093/cvr/cvr067 PubMedCrossRef

58.

Li P, Oparil S, Feng W, Chen YF (2004) Hypoxia-responsive growth factors upregulate periostin and osteopontin expression via distinct signaling pathways in rat pulmonary arterial smooth muscle cells. J Appl Physiol 97:1550–1558. doi:10.1152/japplphysiol.01311.2003 (discussion 1549) PubMedCrossRef

59.

Li P, Oparil S, Novak L, Cao X, Shi W, Lucas J, Chen YF (2007) ANP signaling inhibits TGF-beta-induced Smad2 and Smad3 nuclear translocation and extracellular matrix expression in rat pulmonary arterial smooth muscle cells. J Appl Physiol 102:390–398. doi:10.1152/japplphysiol.00468.2006 PubMedCrossRef

60.

Lin Z, Pu WT (2014) Harnessing Hippo in the heart: Hippo/Yap signaling and applications to heart regeneration and rejuvenation. Stem Cell Res 13:571–581. doi:10.1016/j.scr.2014.04.010 PubMedPubMedCentralCrossRef

61.

Lindner V, Wang Q, Conley BA, Friesel RE, Vary CP (2005) Vascular injury induces expression of periostin: implications for vascular cell differentiation and migration. Arterioscler Thromb Vasc Biol 25:77–83. doi:10.1161/01.ATV.0000149141.81230.c6 PubMed

62.

Lindsley A, Li W, Wang J, Maeda N, Rogers R, Conway SJ (2005) Comparison of the four mouse fasciclin-containing genes expression patterns during valvuloseptal morphogenesis. Gene Expr Patterns 5:593–600. doi:10.1016/j.modgep.2005.03.005 PubMedCrossRef

63.

Ling L, Cheng Y, Ding L, Yang X (2014) Association of serum periostin with cardiac function and short-term prognosis in acute myocardial infarction patients. PLoS One 9:e88755. doi:10.1371/journal.pone.0088755 PubMedPubMedCentralCrossRef

64.

Litvin J, Blagg A, Mu A, Matiwala S, Montgomery M, Berretta R, Houser S, Margulies K (2006) Periostin and periostin-like factor in the human heart: possible therapeutic targets. Cardiovasc Pathol 15:24–32. doi:10.1016/j.carpath.2005.09.001 PubMedCrossRef

65.

Litvin J, Chen X, Keleman S, Zhu S, Autieri M (2007) Expression and function of periostin-like factor in vascular smooth muscle cells. Am J Physiol Cell Physiol 292:C1672–C1680. doi:10.1152/ajpcell.00153.2006 PubMedCrossRef

66.

Litvin J, Selim AH, Montgomery MO, Lehmann K, Rico MC, Devlin H, Bednarik DP, Safadi FF (2004) Expression and function of periostin-isoforms in bone. J Cell Biochem 92:1044–1061. doi:10.1002/jcb.20115 PubMedCrossRef

67.

Litvin J, Zhu S, Norris R, Markwald R (2005) Periostin family of proteins: therapeutic targets for heart disease. Anat Rec A Discov Mol Cell Evol Biol 287:1205–1212. doi:10.1002/ar.a.20237 PubMedCrossRef

68.

Liu F, Lagares D, Choi KM, Stopfer L, Marinkovic A, Vrbanac V, Probst CK, Hiemer SE, Sisson TH, Horowitz JC, Rosas IO, Fredenburgh LE, Feghali-Bostwick C, Varelas X, Tager AM, Tschumperlin DJ (2015) Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis. Am J Physiol Lung Cell Mol Physiol 308:L344–L357. doi:10.1152/ajplung.00300.2014 PubMedCrossRef

69.

Lorts A, Schwanekamp JA, Elrod JW, Sargent MA, Molkentin JD (2009) Genetic manipulation of periostin expression in the heart does not affect myocyte content, cell cycle activity, or cardiac repair. Circ Res 104:e1–e7. doi:10.1161/CIRCRESAHA.108.188649 PubMedCrossRef

70.

Ma Y, Iyer RP, Jung M, Czubryt MP, Lindsey ML (2017) Cardiac fibroblast activation post-myocardial infarction: current knowledge gaps. Trends Pharmacol Sci 38:448–458. doi:10.1016/j.tips.2017.03.001 PubMedCrossRef

71.

Markwald RR, Norris RA, Moreno-Rodriguez R, Levine RA (2010) Developmental basis of adult cardiovascular diseases: valvular heart diseases. Ann N Y Acad Sci 1188:177–183. doi:10.1111/j.1749-6632.2009.05098.x PubMedPubMedCentralCrossRef

72.

Martin-Rojas T, Mourino-Alvarez L, Alonso-Orgaz S, Rosello-Lleti E, Calvo E, Lopez-Almodovar LF, Rivera M, Padial LR, Lopez JA, de la Cuesta F, Barderas MG (2015) iTRAQ proteomic analysis of extracellular matrix remodeling in aortic valve disease. Sci Rep 5:17290. doi:10.1038/srep17290 PubMedPubMedCentralCrossRef

73.

Maruhashi T, Kii I, Saito M, Kudo A (2010) Interaction between periostin and BMP-1 promotes proteolytic activation of lysyl oxidase. J Biol Chem 285:13294–13303. doi:10.1074/jbc.M109.088864 PubMedPubMedCentralCrossRef

74.

Meyer S, van der Meer P, Massie BM, O’Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Davison BA, Cleland JG, Givertz MM, Bloomfield DM, Fiuzat M, Dittrich HC, Hillege HL, Voors AA (2013) Sex-specific acute heart failure phenotypes and outcomes from PROTECT. Eur J Heart Fail 15:1374–1381. doi:10.1093/eurjhf/hft115 PubMedCrossRef

75.

Moody RG, Williamson MP (2013) Structure and function of a bacterial Fasciclin I Domain Protein elucidates function of related cell adhesion proteins such as TGFBIp and periostin. FEBS Open Bio 3:71–77. doi:10.1016/j.fob.2013.01.001 PubMedPubMedCentralCrossRef

76.

Morita H, Komuro I (2016) Periostin isoforms and cardiac remodeling after myocardial infarction: is the dispute settled? Hypertension 67:504–505. doi:10.1161/HYPERTENSIONAHA.115.06449 PubMed

77.

Niu Z, Li A, Zhang SX, Schwartz RJ (2007) Serum response factor micromanaging cardiogenesis. Curr Opin Cell Biol 19:618–627. doi:10.1016/j.ceb.2007.09.013 PubMedPubMedCentralCrossRef

78.

Norris RA, Damon B, Mironov V, Kasyanov V, Ramamurthi A, Moreno-Rodriguez R, Trusk T, Potts JD, Goodwin RL, Davis J, Hoffman S, Wen X, Sugi Y, Kern CB, Mjaatvedt CH, Turner DK, Oka T, Conway SJ, Molkentin JD, Forgacs G, Markwald RR (2007) Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues. J Cell Biochem 101:695–711. doi:10.1002/jcb.21224 PubMedPubMedCentralCrossRef

79.

Norris RA, Kern CB, Wessels A, Moralez EI, Markwald RR, Mjaatvedt CH (2004) Identification and detection of the periostin gene in cardiac development. Anat Rec A Discov Mol Cell Evol Biol 281:1227–1233. doi:10.1002/ar.a.20135 PubMedCrossRef

80.

Norris RA, Moreno-Rodriguez R, Hoffman S, Markwald RR (2009) The many facets of the matricelluar protein periostin during cardiac development, remodeling, and pathophysiology. J Cell Commun Signal 3:275–286. doi:10.1007/s12079-009-0063-5 PubMedPubMedCentralCrossRef

81.

Norris RA, Moreno-Rodriguez RA, Sugi Y, Hoffman S, Amos J, Hart MM, Potts JD, Goodwin RL, Markwald RR (2008) Periostin regulates atrioventricular valve maturation. Dev Biol 316:200–213. doi:10.1016/j.ydbio.2008.01.003 PubMedPubMedCentralCrossRef

82.

Norris RA, Potts JD, Yost MJ, Junor L, Brooks T, Tan H, Hoffman S, Hart MM, Kern MJ, Damon B, Markwald RR, Goodwin RL (2009) Periostin promotes a fibroblastic lineage pathway in atrioventricular valve progenitor cells. Dev Dyn 238:1052–1063. doi:10.1002/dvdy.21933 PubMedPubMedCentralCrossRef

83.

Ohta S, Okamoto M, Fujimoto K, Sakamoto N, Takahashi K, Yamamoto H, Kushima H, Ishii H, Akasaka K, Ono J, Kamei A, Azuma Y, Matsumoto H, Yamaguchi Y, Aihara M, Johkoh T, Kawaguchi A, Ichiki M, Sagara H, Kadota JI, Hanaoka M, Hayashi SI, Kohno S, Hoshino T, Izuhara K, Consortium for Development of Diagnostics for Pulmonary Fibrosis Patients (2017) The usefulness of monomeric periostin as a biomarker for idiopathic pulmonary fibrosis. PLoS One 12:e0174547. doi:10.1371/journal.pone.0174547 PubMedPubMedCentralCrossRef

84.

Oka T, Xu J, Kaiser RA, Melendez J, Hambleton M, Sargent MA, Lorts A, Brunskill EW, Dorn GW 2nd, Conway SJ, Aronow BJ, Robbins J, Molkentin JD (2007) Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ Res 101:313–321. doi:10.1161/CIRCRESAHA.107.149047 PubMedPubMedCentralCrossRef

85.

Oku E, Kanaji T, Takata Y, Oshima K, Seki R, Morishige S, Imamura R, Ohtsubo K, Hashiguchi M, Osaki K, Yakushiji K, Yoshimoto K, Ogata H, Hamada H, Izuhara K, Sata M, Okamura T (2008) Periostin and bone marrow fibrosis. Int J Hematol 88:57–63. doi:10.1007/s12185-008-0095-2 PubMedCrossRef

86.

Patel NH, Snow PM, Goodman CS (1987) Characterization and cloning of fasciclin III: a glycoprotein expressed on a subset of neurons and axon pathways in Drosophila. Cell 48:975–988. doi:10.1016/0092-8674(87)90706-9 PubMedCrossRef

87.

Pessah M, Prunier C, Marais J, Ferrand N, Mazars A, Lallemand F, Gauthier JM, Atfi A (2001) c-Jun interacts with the corepressor TG-interacting factor (TGIF) to suppress Smad2 transcriptional activity. Proc Natl Acad Sci USA 98:6198–6203. doi:10.1073/pnas.101579798 PubMedPubMedCentralCrossRef

88.

Petrov G, Dworatzek E, Schulze TM, Dandel M, Kararigas G, Mahmoodzadeh S, Knosalla C, Hetzer R, Regitz-Zagrosek V (2014) Maladaptive remodeling is associated with impaired survival in women but not in men after aortic valve replacement. JACC Cardiovasc Imaging 7:1073–1080. doi:10.1016/j.jcmg.2014.06.017 PubMedCrossRef

89.

Politz O, Gratchev A, McCourt PA, Schledzewski K, Guillot P, Johansson S, Svineng G, Franke P, Kannicht C, Kzhyshkowska J, Longati P, Velten FW, Johansson S, Goerdt S (2002) Stabilin-1 and -2 constitute a novel family of fasciclin-like hyaluronan receptor homologues. Biochem J 362:155–164. doi:10.1042/bj3620155 PubMedPubMedCentral

90.

Ruan K, Bao S, Ouyang G (2009) The multifaceted role of periostin in tumorigenesis. Cell Mol Life Sci 66:2219–2230. doi:10.1007/s00018-009-0013-7 PubMedCrossRef

91.

Sasaki H, Yu C-Y, Dai M, Tam C, Loda M, Auclair D, Chen LB, Elias A (2003) Elevated serum periostin levels in patients with bone metastases from breast but not lung cancer. Breast Cancer Res Treat 77:245–252. doi:10.1023/a:1021899904332 PubMedCrossRef

92.

Sen K, Lindenmeyer MT, Gaspert A, Eichinger F, Neusser MA, Kretzler M, Segerer S, Cohen CD (2011) Periostin is induced in glomerular injury and expressed de novo in interstitial renal fibrosis. Am J Pathol 179:1756–1767. doi:10.1016/j.ajpath.2011.06.002 PubMedPubMedCentralCrossRef

93.

Shih CH, Lacagnina M, Leuer-Bisciotti K, Proschel C (2014) Astroglial-derived periostin promotes axonal regeneration after spinal cord injury. J Neurosci 34:2438–2443. doi:10.1523/JNEUROSCI.2947-13.2014 PubMedCrossRef

94.

Shimazaki M, Nakamura K, Kii I, Kashima T, Amizuka N, Li M, Saito M, Fukuda K, Nishiyama T, Kitajima S, Saga Y, Fukayama M, Sata M, Kudo A (2008) Periostin is essential for cardiac healing after acute myocardial infarction. J Exp Med 205:295–303. doi:10.1084/jem.20071297 PubMedPubMedCentralCrossRef

95.

Skonier J, Bennett K, Rothwell V, Kosowski S, Plowman G, Wallace P, Edelhoff S, Disteche C, Neubauer M, Marquardt H et al (1994) beta ig-h3: a transforming growth factor-beta-responsive gene encoding a secreted protein that inhibits cell attachment in vitro and suppresses the growth of CHO cells in nude mice. DNA Cell Biol 13:571–584. doi:10.1089/dna.1994.13.571 PubMedCrossRef

96.

Snider P, Hinton RB, Moreno-Rodriguez RA, Wang J, Rogers R, Lindsley A, Li F, Ingram DA, Menick D, Field L, Firulli AB, Molkentin JD, Markwald R, Conway SJ (2008) Periostin is required for maturation and extracellular matrix stabilization of noncardiomyocyte lineages of the heart. Circ Res 102:752–760. doi:10.1161/CIRCRESAHA.107.159517 PubMedPubMedCentralCrossRef

97.

Spinale FG, Frangogiannis NG, Hinz B, Holmes JW, Kassiri Z, Lindsey ML (2016) Crossing into the next frontier of cardiac extracellular matrix research. Circ Res 119:1040–1045. doi:10.1161/CIRCRESAHA.116.309916 PubMedPubMedCentralCrossRef

98.

Stanton LW, Garrard LJ, Damm D, Garrick BL, Lam A, Kapoun AM, Zheng Q, Protter AA, Schreiner GF, White RT (2000) Altered patterns of gene expression in response to myocardial infarction. Circ Res 86:939–945. doi:10.1161/01.RES.86.9.939 PubMedCrossRef

99.

Takayama G, Arima K, Kanaji T, Toda S, Tanaka H, Shoji S, McKenzie AN, Nagai H, Hotokebuchi T, Izuhara K (2006) Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J Allergy Clin Immunol 118:98–104. doi:10.1016/j.jaci.2006.02.046 PubMedCrossRef

100.

Takeshita S, Kikuno R, Tezuka K, Amann E (1993) Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem J 294(Pt 1):271–278. doi:10.1042/bj2940271 PubMedPubMedCentralCrossRef

101.

Tan HL, Glen E, Topf A, Hall D, O’Sullivan JJ, Sneddon L, Wren C, Avery P, Lewis RJ, ten Dijke P, Arthur HM, Goodship JA, Keavney BD (2012) Nonsynonymous variants in the SMAD6 gene predispose to congenital cardiovascular malformation. Hum Mutat 33:720–727. doi:10.1002/humu.22030 PubMedPubMedCentralCrossRef

102.

Taniyama Y, Katsuragi N, Sanada F, Azuma J, Iekushi K, Koibuchi N, Okayama K, Ikeda-Iwabu Y, Muratsu J, Otsu R, Rakugi H, Morishita R (2016) Selective blockade of periostin exon 17 preserves cardiac performance in acute myocardial infarction. Hypertension 67:356–361. doi:10.1161/HYPERTENSIONAHA.115.06265 PubMed

103.

Tkatchenko TV, Moreno-Rodriguez RA, Conway SJ, Molkentin JD, Markwald RR, Tkatchenko AV (2009) Lack of periostin leads to suppression of Notch1 signaling and calcific aortic valve disease. Physiol Genom 39:160–168. doi:10.1152/physiolgenomics.00078.2009 CrossRef

104.

Utispan K, Sonongbua J, Thuwajit P, Chau-In S, Pairojkul C, Wongkham S, Thuwajit C (2012) Periostin activates integrin alpha5beta1 through a PI3K/AKT dependent pathway in invasion of cholangiocarcinoma. Int J Oncol 41:1110–1118. doi:10.3892/ijo.2012.1530 PubMedCrossRef

105.

van Amerongen MJ, Bou-Gharios G, Popa E, van Ark J, Petersen AH, van Dam GM, van Luyn MJ, Harmsen MC (2008) Bone marrow-derived myofibroblasts contribute functionally to scar formation after myocardial infarction. J Pathol 214:377–386. doi:10.1002/path.2281 PubMedCrossRef

106.

Varelas X (2014) The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease. Development 141:1614–1626. doi:10.1242/dev.102376 PubMedCrossRef

107.

Walker JT, McLeod K, Kim S, Conway SJ, Hamilton DW (2016) Periostin as a multifunctional modulator of the wound healing response. Cell Tissue Res 365:453–465. doi:10.1007/s00441-016-2426-6 PubMedPubMedCentralCrossRef

108.

Wang D, Oparil S, Feng JA, Li P, Perry G, Chen LB, Dai M, John SW, Chen YF (2003) Effects of pressure overload on extracellular matrix expression in the heart of the atrial natriuretic peptide-null mouse. Hypertension 42:88–95. doi:10.1161/01.HYP.0000074905.22908.A6 PubMedCrossRef

109.

Wipff PJ, Rifkin DB, Meister JJ, Hinz B (2007) Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J Cell Biol 179:1311–1323. doi:10.1083/jcb.200704042 PubMedPubMedCentralCrossRef

110.

Wu H, Chen L, Xie J, Li R, Li GN, Chen QH, Zhang XL, Kang LN, Xu B (2016) Periostin expression induced by oxidative stress contributes to myocardial fibrosis in a rat model of high salt-induced hypertension. Mol Med Rep 14:776–782. doi:10.3892/mmr.2016.5308 PubMedPubMedCentralCrossRef

111.

Wu H, Li GN, Xie J, Li R, Chen QH, Chen JZ, Wei ZH, Kang LN, Xu B (2016) Resveratrol ameliorates myocardial fibrosis by inhibiting ROS/ERK/TGF-beta/periostin pathway in STZ-induced diabetic mice. BMC Cardiovasc Disord 16:5. doi:10.1186/s12872-015-0169-z PubMedPubMedCentralCrossRef

112.

Wu H, Xie J, Li GN, Chen QH, Li R, Zhang XL, Kang LN, Xu B (2015) Possible involvement of TGF-beta/periostin in fibrosis of right atrial appendages in patients with atrial fibrillation. Int J Clin Exp Pathol 8:6859–6869. https://www-ncbi-nlm-nih-gov.uml.idm.oclc.org/pmc/articles/PMC4525907/

113.

Xu J, Cui G, Esmailian F, Plunkett M, Marelli D, Ardehali A, Odim J, Laks H, Sen L (2004) Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation. Circulation 109:363–368. doi:10.1161/01.CIR.0000109495.02213.52 PubMedCrossRef

114.

Yamashita O, Yoshimura K, Nagasawa A, Ueda K, Morikage N, Ikeda Y, Hamano K (2013) Periostin links mechanical strain to inflammation in abdominal aortic aneurysm. PLoS One 8:e79753. doi:10.1371/journal.pone.0079753 PubMedPubMedCentralCrossRef

115.

Yuan CT, Li XX, Cheng QJ, Wang YH, Wang JH, Liu CL (2015) MiR-30a regulates the atrial fibrillation-induced myocardial fibrosis by targeting snail 1. Int J Clin Exp Pathol 8:15527–15536. https://www-ncbi-nlm-nih-gov.uml.idm.oclc.org/pmc/articles/PMC4730035/

116.

Zhao S, Wu H, Xia W, Chen X, Zhu S, Zhang S, Shao Y, Ma W, Yang D, Zhang J (2014) Periostin expression is upregulated and associated with myocardial fibrosis in human failing hearts. J Cardiol 63:373–378. doi:10.1016/j.jjcc.2013.09.013 PubMedCrossRef

117.

Zhong J, Yang HC, Kon V, Fogo AB, Lawrence DA, Ma J (2014) Vitronectin-binding PAI-1 protects against the development of cardiac fibrosis through interaction with fibroblasts. Lab Investig 94:633–644. doi:10.1038/labinvest.2014.51 PubMedPubMedCentralCrossRef

118.

Zhou J (2014) An emerging role for Hippo-YAP signaling in cardiovascular development. J Biomed Res 28:251–254. doi:10.7555/JBR.28.20140020 PubMedPubMedCentral

Title: Periostin in cardiovascular disease and development: a tale of two distinct roles
Authors: Natalie M. Landry
Smadar Cohen
Ian M. C. Dixon
Publication date: 01-01-2018
Publisher: Springer Berlin Heidelberg
Published in: Basic Research in Cardiology / Issue 1/2018
Print ISSN: 0300-8428
Electronic ISSN: 1435-1803
DOI: https://doi.org/10.1007/s00395-017-0659-5

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Periostin in cardiovascular disease and development: a tale of two distinct roles

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2018

AMPK-dependent nitric oxide release provides contractile support during hyperosmotic stress

Pre- and postconditioning the heart with hydrogen sulfide (H2S) against ischemia/reperfusion injury in vivo: a systematic review and meta-analysis

The RISK pathway and beyond

STAT3 as a common signal of ischemic conditioning: a lesson on “rigor and reproducibility” in preclinical studies on cardioprotection

Survival pathways in cardiac conditioning: individual data vs. meta-analyses. What do we learn?

Gene expression analysis to identify mechanisms underlying heart failure susceptibility in mice and humans

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page